Stocks to watch on July 11

📌SBI raised ₹10,000 crore at a coupon rate of 7.36% through its sixth infrastructure bond issuance. 📌Zydus Lifesciences received tentative approval from the US FDA to market diroximel fumarate delayed-release capsules, 231 mg. 📌Kesoram Industries firm reported a net loss of ₹62 crore for the first quarter that ended June 30, 2024.